PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Dr. Ajit Limaye and Dr. Camille Kotton (@KottonNelson) join Dr. Erin McCreary (@ErinMcCreary) to discuss fascinating updates in the CMV space including new RCTs for prevention, vaccines, and more! Learn why a little “hair of the dog” might be a good thing, how great T cells are, and the trials we still need.
References:
- Letermovir vs Valganciclovir for Prevention in Kidney Transplant: Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial – PubMed (nih.gov)
Abhijit (Ajit) Limaye, MD
Dr. Ajit Lamaye is a board-certified physician at the Infectious Diseases and Tropical Medicine Clinic and Kidney Care and Transplantation Services at University of Washington Medical Center. He is also the Director of the UW Solid Organ Transplant Infectious Diseases Program. Dr. Lamaye is a Professor of Medicine, Allergy and Infectious Diseases as well as an Adjunct Professor of Laboratory Medicine. HIs clinical and research interests include prevention, diagnosis, and treatment of infections in both solid organ transplant and cell transplantation patients.
Camille Kotton, MD, FIDSA, FAST
Dr. Cotton is the Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital. Her clinical practice focuses on cell and solid organ transplantation patients. Her interests include vaccination, travel medicine for transplant recipients, and reducing the infectious risks of immunocompromising medications. She recently served as the lead author for Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.
